Denham Wisdom

Denham Wisdom is an experienced Medical Scientific Liaison currently working at Amarin Corporation since December 2021. Prior to this role, Denham held various positions within the pharmaceutical industry, including Contract Medical Science Liaison Manager (Diabetes) at Boehringer Ingelheim from January 2016 to January 2022, and Contract Medical Science Liaison Consultant (Cardio-Metabolic) at Novartis from March 2015 to November 2015. Denham also served as a Regional Medical Advisor at Novo Nordisk A/S from July 2012 to December 2014, Scientific Advisor (Primary Care Europe and Canada) at Pfizer from April 2010 to June 2012, and Scientific Advisor at sanofi-aventis from 2006 to 2010. This extensive background in medical science liaison roles highlights Denham's expertise in the pharmaceutical sector.